应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PPCB Propanc Biopharma, Inc.
盘后交易 12-08 18:55:03 EST
0.8364
-0.0029
-0.35%
盘后
0.8364
+0.0000
0.00%
18:52 EST
最高
0.8393
最低
0.8050
成交量
4.08万
今开
0.8141
昨收
0.8393
日振幅
4.09%
总市值
1,118万
流通市值
284.75万
总股本
1,336万
成交额
3.33万
换手率
1.20%
流通股本
340.45万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Propanc Biopharma, Inc.盘中异动 早盘股价大涨5.23%报0.847美元
市场透视 · 11-28
Propanc Biopharma, Inc.盘中异动 早盘股价大涨5.23%报0.847美元
Propanc Biopharma, Inc.盘中异动 早盘股价大跌5.64%
市场透视 · 11-14
Propanc Biopharma, Inc.盘中异动 早盘股价大跌5.64%
Propanc Biopharma, Inc.盘中异动 大幅跳水5.65%报0.851美元
市场透视 · 11-11
Propanc Biopharma, Inc.盘中异动 大幅跳水5.65%报0.851美元
Propanc Biopharma, Inc. 进行战略收购计划,瞄准市值低于净资产价值的数字资产财政公司
美股速递 · 11-04
Propanc Biopharma, Inc. 进行战略收购计划,瞄准市值低于净资产价值的数字资产财政公司
Propanc Biopharma与Hexstone Capital达成高达1亿美元的战略融资协议
美股速递 · 10-15
Propanc Biopharma与Hexstone Capital达成高达1亿美元的战略融资协议
美国监管、财库模式强劲、财报给力,降息后首日,币圈“币股齐升”
华尔街见闻 · 09-19
美国监管、财库模式强劲、财报给力,降息后首日,币圈“币股齐升”
特朗普儿子:加密货币将“拯救美元”
华尔街见闻 · 09-19
特朗普儿子:加密货币将“拯救美元”
Propanc Biopharma, Inc.8月19日成交额为1044.07万美元
市场透视 · 08-20
Propanc Biopharma, Inc.8月19日成交额为1044.07万美元
加载更多
公司概况
公司名称:
Propanc Biopharma, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Propanc Biopharma, Inc.最初于2007年10月15日在澳大利亚维多利亚州墨尔本成立。2010年11月23日,该公司在特拉华州重新注册并重新注册。他们是一家发展阶段的医疗保健公司,目前专注于为患有胰腺癌、卵巢癌和癌症的患者开发新的癌症治疗方法。利用他们的科学和肿瘤学顾问,他们开发了一种合理的抗癌化合物复合配方,这些化合物共同发挥多种作用,旨在控制或防止肿瘤在体内复发和扩散。他们的主要候选产品PRP是他们新配方的变体,涉及酶原,即酶的无活性前体。
发行价格:
--
{"stockData":{"symbol":"PPCB","market":"US","secType":"STK","nameCN":"Propanc Biopharma, Inc.","latestPrice":0.8364,"timestamp":1765227600000,"preClose":0.8393,"halted":0,"volume":40780,"hourTrading":{"tag":"盘后","latestPrice":0.8364,"preClose":0.8364,"latestTime":"18:52 EST","volume":1960,"amount":1593.1427624,"timestamp":1765237945668},"delay":0,"floatShares":3404500,"shares":13364244,"eps":-8.995654,"marketStatus":"盘后交易","change":-0.0029,"latestTime":"12-08 18:55:03 EST","open":0.8141,"high":0.8393,"low":0.805,"amount":33315.535006,"amplitude":0.040867,"askPrice":0.8499,"askSize":99,"bidPrice":0.805,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-8.995654,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1765242000000},"marketStatusCode":4,"adr":0,"listingDate":1743998400000,"exchange":"NASDAQ","adjPreClose":0.8393,"preHourTrading":{"tag":"盘前","latestPrice":0.8007,"preClose":0.839,"latestTime":"09:28 EST","volume":1605,"amount":1295.5121835,"timestamp":1765204083191},"postHourTrading":{"tag":"盘后","latestPrice":0.8364,"preClose":0.8364,"latestTime":"18:52 EST","volume":1960,"amount":1593.1427624,"timestamp":1765237945668},"volumeRatio":0.044299},"requestUrl":"/m/hq/s/PPCB","defaultTab":"news","newsList":[{"id":"2587998737","title":"Propanc Biopharma, Inc.盘中异动 早盘股价大涨5.23%报0.847美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2587998737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587998737?lang=zh_cn&edition=full","pubTime":"2025-11-28 23:38","pubTimestamp":1764344314,"startTime":"0","endTime":"0","summary":"北京时间2025年11月28日23时38分,Propanc Biopharma, Inc.股票出现波动,股价急速拉升5.23%。Propanc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大,Aditxt, Inc.、Pasithea Therapeutics Corp.、Cdt Equity Inc.较为活跃,换手率分别为3825.43%、1505.30%、241.69%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为111.14%、67.92%、35.60%。Propanc Biopharma, Inc.公司简介:Propanc Biopharma Inc是一家处于发展阶段的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128233835a717e595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128233835a717e595&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PPCBD","PPCB","BK4139"],"gpt_icon":0},{"id":"2583579368","title":"Propanc Biopharma, Inc.盘中异动 早盘股价大跌5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583579368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583579368?lang=zh_cn&edition=full","pubTime":"2025-11-14 00:09","pubTimestamp":1763050183,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日00时09分,Propanc Biopharma, Inc.股票出现波动,股价大幅下跌5.64%。Propanc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.56%。其相关个股中,Mersana Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Outlook Therapeutics, Inc.涨幅较大,Clearmind Medicine Inc.、Salarius Pharmaceuticals, Inc.、Outlook Therapeutics, Inc.较为活跃,换手率分别为4887.22%、407.27%、67.00%,振幅较大的相关个股有Clearmind Medicine Inc.、Outlook Therapeutics, Inc.、Osr Holdings Inc C/Wts 09/02/2028 ,振幅分别为107.67%、30.47%、29.51%。Propanc Biopharma, Inc.公司简介:Propanc Biopharma Inc是一家处于发展阶段的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114000944950293d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114000944950293d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PPCB","BK4139","PPCBD"],"gpt_icon":0},{"id":"2582165663","title":"Propanc Biopharma, Inc.盘中异动 大幅跳水5.65%报0.851美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582165663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582165663?lang=zh_cn&edition=full","pubTime":"2025-11-11 23:41","pubTimestamp":1762875678,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日23时41分,Propanc Biopharma, Inc.股票出现波动,股价大幅下挫5.65%。Propanc Biopharma, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。其相关个股中,Engene Holdings Inc C/Wts 31/10/2028 Cl A、Engene Holdings Inc.、Quoin Pharmaceuticals Ltd涨幅较大,Quoin Pharmaceuticals Ltd、Aspire Biopharma Holdings, Inc.、Salarius Pharmaceuticals, Inc.较为活跃,换手率分别为2627.31%、345.35%、282.14%,振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028 Cl A、Quoin Pharmaceuticals Ltd、Engene Holdings Inc.,振幅分别为72.31%、58.48%、54.91%。Propanc Biopharma, Inc.公司简介:Propanc Biopharma Inc是一家处于发展阶段的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511112341189762cb1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511112341189762cb1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PPCB","BK4139","PPCBD"],"gpt_icon":0},{"id":"1130774186","title":"Propanc Biopharma, Inc. 进行战略收购计划,瞄准市值低于净资产价值的数字资产财政公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1130774186","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130774186?lang=zh_cn&edition=full","pubTime":"2025-11-04 20:01","pubTimestamp":1762257670,"startTime":"0","endTime":"0","summary":"Propanc Biopharma, Inc. 进行战略收购计划,瞄准市值低于净资产价值的数字资产财政公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"gpt_icon":0},{"id":"1139253764","title":"Propanc Biopharma与Hexstone Capital达成高达1亿美元的战略融资协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1139253764","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139253764?lang=zh_cn&edition=full","pubTime":"2025-10-15 20:45","pubTimestamp":1760532334,"startTime":"0","endTime":"0","summary":"Propanc Biopharma与Hexstone Capital达成高达1亿美元的战略融资协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"gpt_icon":0},{"id":"1187004928","title":"美国监管、财库模式强劲、财报给力,降息后首日,币圈“币股齐升”","url":"https://stock-news.laohu8.com/highlight/detail?id=1187004928","media":"华尔街见闻","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187004928?lang=zh_cn&edition=full","pubTime":"2025-09-19 16:44","pubTimestamp":1758271470,"startTime":"0","endTime":"0","summary":"美联储降息首日,加密货币市场全面上涨,比特币突破11.7万美元,数字资产交易所股价大涨。监管转向、资金涌入与亮眼财报形成共振效应:一是SEC新规将数字资产ETF审批时间从240天缩短至75天,为更多加密货币ETF铺路;二是财库模式获追捧,木头姐联手阿联酋3亿美元押注Solana财库公司;三是Bullish交易所扭亏为盈并获得纽约监管牌照。","market":"us","thumbnail":"https://static.tigerbbs.com/6f743d717b6a2f2140fa7df544d4c12c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6f743d717b6a2f2140fa7df544d4c12c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"be98285368f3586ab1487190e5f718fe","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COSM","02888","LTC.USD.CC","ICG","02598","BTCO","COMP.USD.CC","00165","BMNR","LINK.USD.CC","CETH","SOS","ETHA","01328","BTCW","COIN","FETH","ATOM.USD.HKCC","LDO.USD.HKCC","CAN","MATIC.USD.CC","QETH","IBIT","DOT.USD.CC","FBTC","09618","BTC.USD.CC","AVAX.USD.CC","DYDX.USD.HKCC","ETHE","00863","ETH.USD.CC","EZBC","PPCB","BTCS","ARKB","SBET","BITO","OP.USD.HKCC","EBON","BITB","09959","ETHW","DEFI","UNI.USD.CC","09923","SNX.USD.CC","AAVE.USD.CC","MSTR","CLSK","06060","BTCT","HODL","RIOT","RNDR.USD.HKCC","ETH","GBTC","MARA","BTM","BTBT","BTCM","MKR.USD.CC","BRRR","ETHV","NCTY","USDT.USD.CC","EZET"],"gpt_icon":1},{"id":"1197229382","title":"特朗普儿子:加密货币将“拯救美元”","url":"https://stock-news.laohu8.com/highlight/detail?id=1197229382","media":"华尔街见闻","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197229382?lang=zh_cn&edition=full","pubTime":"2025-09-19 08:44","pubTimestamp":1758242675,"startTime":"0","endTime":"0","summary":"据报道,Eric Trump称,通过吸引全球资本流入美国数字资产市场,可以为美元提供新的支撑。他的核心逻辑是,一个对数字资产友好的美国将成为全球资本的避风港。当投资者寻求将资金从“不稳定的货币”中转移出来时,美国的加密市场将提供一个有吸引力的选择,从而间接支撑对美元计价资产的需求。\n","market":"us","thumbnail":"https://community-static.tradeup.com/news/2dab22c0fef63e984abe5f41f3c51132","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/2dab22c0fef63e984abe5f41f3c51132"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2c96d496c4829a01b5c378e5f9b4cc21","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTCS","02598","LDO.USD.HKCC","09923","EBON","SNX.USD.CC","COSM","DYDX.USD.HKCC","ETH","NCTY","RIOT","09959","FBTC","EZET","ETHW","MSTR","LTC.USD.CC","PPCB","AAVE.USD.CC","SBET","ARKB","LINK.USD.CC","USDT.USD.CC","BITB","RNDR.USD.HKCC","06060","IBIT","BTM","00863","AVAX.USD.CC","MARA","HODL","BMNR","OP.USD.HKCC","BTCW","UNI.USD.CC","BTCT","COIN","COMP.USD.CC","DEFI","DOT.USD.CC","00165","02888","ETHA","GBTC","BITO","BTC.USD.CC","01328","CETH","BTCO","BRRR","FETH","ICG","MATIC.USD.CC","CAN","ATOM.USD.HKCC","MKR.USD.CC","ETH.USD.CC","QETH","BTCM","BTBT","ETHE","09618","ETHV","EZBC","CLSK","SOS"],"gpt_icon":1},{"id":"2560610965","title":"Propanc Biopharma, Inc.8月19日成交额为1044.07万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560610965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560610965?lang=zh_cn&edition=full","pubTime":"2025-08-20 13:54","pubTimestamp":1755669263,"startTime":"0","endTime":"0","summary":"美东时间2025年8月19日,Propanc Biopharma, Inc.成交额为1044.07万美元,成交额较昨日减少97.97%,当日成交量为244.16万股。Propanc Biopharma, Inc.于2025年8月19日跌37.26%,报3.67美元,该股过去5个交易日跌40.9%,年初至今跌93.88%,过去60日涨84.42%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-08-19|1044.07万|-97.97%|244.16万|#|2025-08-18|5.14亿|29854.84%|6811.68万|#|2025-08-15|171.74万|6755.27%|50.76万|#|2025-08-14|2.51万|-46.27%|2985.00|#|2025-08-13|4.66万|42.77%|8701.00|(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820135434a4934904&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820135434a4934904&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PPCB","PPCBD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.propanc.com","stockEarnings":[{"period":"1week","weight":-0.0608},{"period":"1month","weight":-0.2887},{"period":"3month","weight":-0.6096},{"period":"6month","weight":-0.8736},{"period":"1year","weight":2796.6667},{"period":"ytd","weight":4195.5}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Propanc Biopharma, Inc.最初于2007年10月15日在澳大利亚维多利亚州墨尔本成立。2010年11月23日,该公司在特拉华州重新注册并重新注册。他们是一家发展阶段的医疗保健公司,目前专注于为患有胰腺癌、卵巢癌和癌症的患者开发新的癌症治疗方法。利用他们的科学和肿瘤学顾问,他们开发了一种合理的抗癌化合物复合配方,这些化合物共同发挥多种作用,旨在控制或防止肿瘤在体内复发和扩散。他们的主要候选产品PRP是他们新配方的变体,涉及酶原,即酶的无活性前体。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.250208},{"month":2,"riseRate":0,"avgChangeRate":-0.435416},{"month":3,"riseRate":0,"avgChangeRate":-0.122004},{"month":4,"riseRate":0,"avgChangeRate":-0.570113},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.073453},{"month":6,"riseRate":0.666667,"avgChangeRate":0.742287},{"month":7,"riseRate":0.25,"avgChangeRate":-0.019906},{"month":8,"riseRate":0,"avgChangeRate":-0.482224},{"month":9,"riseRate":0,"avgChangeRate":-0.414214},{"month":10,"riseRate":0,"avgChangeRate":-0.267792},{"month":11,"riseRate":0,"avgChangeRate":-0.325477},{"month":12,"riseRate":0.25,"avgChangeRate":-0.093098}],"exchange":"NASDAQ","name":"Propanc Biopharma, Inc.","nameEN":"Propanc Biopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Propanc Biopharma, Inc.(PPCB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Propanc Biopharma, Inc.(PPCB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Propanc Biopharma, Inc.,PPCB,Propanc Biopharma, Inc.股票,Propanc Biopharma, Inc.股票老虎,Propanc Biopharma, Inc.股票老虎国际,Propanc Biopharma, Inc.行情,Propanc Biopharma, Inc.股票行情,Propanc Biopharma, Inc.股价,Propanc Biopharma, Inc.股市,Propanc Biopharma, Inc.股票价格,Propanc Biopharma, Inc.股票交易,Propanc Biopharma, Inc.股票购买,Propanc Biopharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Propanc Biopharma, Inc.(PPCB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Propanc Biopharma, Inc.(PPCB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}